DK44788D0 - Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion - Google Patents

Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion

Info

Publication number
DK44788D0
DK44788D0 DK044788A DK44788A DK44788D0 DK 44788 D0 DK44788 D0 DK 44788D0 DK 044788 A DK044788 A DK 044788A DK 44788 A DK44788 A DK 44788A DK 44788 D0 DK44788 D0 DK 44788D0
Authority
DK
Denmark
Prior art keywords
cytomegalovirus
weakly
virus
vaccine containing
dna construction
Prior art date
Application number
DK044788A
Other languages
English (en)
Other versions
DK44788A (da
Inventor
Edward S Mocarski
Richard R Spaete
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK44788D0 publication Critical patent/DK44788D0/da
Publication of DK44788A publication Critical patent/DK44788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK044788A 1987-01-30 1988-01-29 Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion DK44788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US927387A 1987-01-30 1987-01-30

Publications (2)

Publication Number Publication Date
DK44788D0 true DK44788D0 (da) 1988-01-29
DK44788A DK44788A (da) 1988-07-31

Family

ID=21736649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK044788A DK44788A (da) 1987-01-30 1988-01-29 Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion

Country Status (3)

Country Link
EP (1) EP0277773A1 (da)
JP (1) JPS63267272A (da)
DK (1) DK44788A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010311A1 (en) * 1987-06-26 1988-12-29 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene and use thereof
GB2214508A (en) * 1988-01-27 1989-09-06 Bayer Ag Plasmid vector for the efficient expression of foreign genes fused with newly conceived transcriptional and translational signal sequences.
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
EP0389286B1 (en) * 1989-03-24 1996-07-10 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US7223411B1 (en) 1992-07-31 2007-05-29 Dana-Farber Cancer Institute Herpesvirus replication defective mutants
US5801235A (en) * 1994-05-25 1998-09-01 Hybridon, Inc. Oligonucleotides with anti-cytomegalovirus activity
EP0914441A2 (en) 1996-04-23 1999-05-12 The Wistar Institute Of Anatomy And Biology Novel human cytomegalovirus dna constructs and uses therefor
US6399354B1 (en) 1998-07-31 2002-06-04 President And Fellows Of Harvard College Replication-competent virus expressing a detectable fusion protein
EP1350113A2 (en) 2000-08-30 2003-10-08 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
CA2437201C (en) * 2001-02-02 2008-11-18 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
CA3028002A1 (en) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
CA1282721C (en) * 1984-06-04 1991-04-09 Bernard Roizman Herpes simplex virus as a vector

Also Published As

Publication number Publication date
EP0277773A1 (en) 1988-08-10
JPS63267272A (ja) 1988-11-04
DK44788A (da) 1988-07-31

Similar Documents

Publication Publication Date Title
DK112586D0 (da) Virus-dna
DK81290A (da) Rekombinante bakterier og malariavaccine indeholdende disse
FI864016A0 (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
DK56086A (da) 11beta-phenylgonaner, deres fremstilling og farmaceutiske indeholdende dem
DK290986D0 (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK272889D0 (da) Vaccine
DK122687D0 (da) Polypeptid, dna og anvendelse deraf
DK518687A (da) Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne
DK209188A (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
DK44788A (da) Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion
DK38989D0 (da) Dna-sekvens
FR2620459B1 (fr) Virus recombinant de la vaccine
DK189788D0 (da) Vaccine
DK127887A (da) Interleukin-1beta-derivater og medikamenter indeholdende saadanne derivater
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
KR890700356A (ko) 신규의 백신
FI840288A0 (fi) Dna-kod av en signalaminosyrasekvens och dna innehaollande densamma
DK199989D0 (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DK698188D0 (da) Peptider, deres fremstilling og anvendelse
DK319888D0 (da) Dna-fragmenter
DK151788D0 (da) Hybridserpiner og dna, som koder derfor
DK375488D0 (da) Vaccine
DK578189A (da) Dna-sekvens
DK202089D0 (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment